Generic Oncology Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

  • ID: 4534990
  • Report
  • Region: Global
  • 82 pages
  • IMARC Group
1 of 3
Driven by rising cancer incidences, patent expiry of a number of blockbuster oncology drugs and the high cost of cancer treatment, the market for generic oncology drugs has been witnessing robust growth. Apart from their strong growth, these drugs also enjoy high product differentiation and entry barriers. As a result, competitive intensity in this segment is also relatively low. This has enabled manufacturer to enjoy higher pricing power and margins compared to commoditised generics.

This latest study “Generic Oncology Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023” provides a comprehensive roadmap for stakeholders who are planning to setup and run a generic Oncology drug manufacturing plant. Aspects such as market size, industry trends, manufacturers, land, construction, machinery, labour, investments, revenues, rate of return, margins, etc. have been thoroughly covered in this report.

Key Questions Answered in This Report:
  • How has the generic drug market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global generic drug industry?
  • What are the various stages in the value chain of the generic drug industry?
  • What are the key driving factors and challenges in the generic drug industry?
  • How has the generic oncology drug market performed so far and how will it perform in the coming years?
  • What is the structure of the generic drug industry and who are the key players?
  • What is the degree of competition in the generic drug industry?
  • What are the profit margins in the generic drug industry?
  • What are the key requirements for setting up generic drug manufacturing plant?
  • How are generic drug manufactured?
  • What are the various unit operations involved in generic drug plant?
  • What is the total size of land required for setting up generic drug plant?
  • What are the machinery requirements for setting up generic drug plant?
  • What are the raw material requirements for setting up generic drug plant?
  • What are the packaging requirements for generic drug?
  • What are the transportation requirements for generic drug?
  • What are the utility requirements for setting up generic drug plant?
  • What are the manpower requirements for setting up generic drug plant?
  • What are the infrastructure costs for setting up generic drug plant?
  • What are the capital costs for setting up generic drug plant?
  • What are the operating costs for setting up generic drug plant?
  • What will be the income and expenditures for generic drug plant?
  • What is the time required to break-even?
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Preface

2. Scope and Methodology
2.1 Objectives of the study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3. Executive Summary

4. Introduction
4.1Overview
4.2Key Industry Trends

5. Global Generic Drug Market
5.1Market Overview
5.2Market Performance
5.3Market Breakup by Region
5.4Market Forecast

6. Global Generic Oncology Drug Market
6.1Market Overview
6.2Market Trends
6.3Top Generic Oncology Drugs
6.4Price Analysis
6.5Market Forecast
6.6SWOT Analysis
6.6.1Strengths
6.6.2Weaknesses
6.6.3Opportunities
6.6.4Threats
6.7Value Chain Analysis
6.7.1Research and Development
6.7.2Manufacturing
6.7.3Marketing
6.7.4Distribution
6.8Porter’s Five Forces Analysis
6.8.1Overview
6.8.2Bargaining Power of Buyers
6.8.3Bargaining Power of Suppliers
6.8.4Degree of Competition
6.8.5Threat of New Entrants
6.8.6Threat of Substitutes
6.8.7Regulations in the Generics Industry
6.9Key Market Drivers and Success Factors

7. Global Generic Oncology Drug Market: Performance of Key Regions
7.1North America
7.2Europe
7.3Asia Pacific
7.4Middle East and Africa
7.5Latin America

8. Global Generic Drug Market: Competitive Landscape
8.1Competitive Structure
8.2Market Breakup by Key Players
8.3Key Player Profiles

9. Generic Oncology Drug Manufacturing Process
9.1Product Overview
9.2Detailed Process Flow (Tablets)
9.3Detailed Process Flow (Injectable)
9.4Various Types of Unit Operations Involved
9.5Mass Balance and Raw Material Requirements

10. Project Details, Requirements and Costs Involved
10.1Land Requirements and Expenditures
10.2Construction Requirements and Expenditures
10.3Plant Machinery
10.4Machinery Pictures
10.5Raw Material Requirements and Expenditures
10.6Packaging Requirements and Expenditures
10.7Transportation Requirements and Expenditures
10.8Utility Requirements and Expenditures
10.9Manpower Requirements and Expenditures
10.10Other Capital Investments

11. Loans and Financial Assistance

12. Project Economics
12.1Capital Cost of the Project
12.2Techno-Economic Parameters
12.3Product Pricing and Margins Across Various Levels of the Supply Chain
12.4Taxation and Depreciation
12.5Income Projections
12.6Expenditure Projections
12.7Financial Analysis
12.8Profit Analysis
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll